MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
589.88%
Quick Ratio
589.88%
Unit: Thousand (K) dollars
Assets Breakdown
    • Available-for-sale securities, a...
    • Right-of-use assets
    • Other current assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible notes, net
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash, cash equivalents and restricted cash-Consolidated Entity Excluding Variable Interest Entities VIE
19,685
147,531
71,370
88,706
Cash, cash equivalents and restricted cash-Variable Interest Entity Primary Beneficiary
35,074
40,986
130,273
137,842
Accounts receivable
8,556
15,685
218,871
6,824
Available-for-sale securities, at fair value and short-term investments
-
1,595,574
714,967
-
Available-for-sale securities, at fair value
1,547,201
-
-
692,818
Prepaid expenses
25,373
21,721
16,053
10,933
Other current assets
35,522
18,254
22,855
13,516
Total current assets
1,671,411
1,839,751
1,174,389
950,639
Property, plant and equipment, net
373,301
374,822
378,584
382,515
Impairment-Licensing Agreements
0
0
0
0
Gross carrying amount
24,857
24,857
24,857
24,857
Accumulated amortization
19,271
18,846
18,421
17,996
Impairment
0
0
0
0
Intangible assets, net
5,586
6,011
6,436
6,861
Right-of-use assets
55,667
42,794
43,361
43,891
Other assets
6,048
4,887
1,411
1,389
Total assets
2,112,013
2,268,265
1,604,181
1,385,295
Accounts payable
27,776
30,747
32,937
17,674
Accrued expenses
86,174
76,585
130,081
90,419
Accrued payroll and benefits
23,455
20,366
14,270
26,895
Lease liabilities
5,322
7,774
7,529
7,289
Deferred revenue
94,596
108,543
111,933
2,399
Credit facility
40,000
40,000
40,000
40,000
Other liabilities
6,023
11,205
10,675
10,811
Total current liabilities
283,346
295,220
347,425
195,487
Lease liabilities, net of current portion
114,298
100,106
102,129
104,112
Deferred revenue, net of current portion
31,743
48,615
53,825
-
Liability related to the sale of future royalties
392,512
383,829
374,997
367,397
Credit facility, net of current portion
141,366
159,639
163,108
214,883
Convertible notes, net
682,707
681,940
-
-
Total long-term liabilities
1,362,626
1,374,129
694,059
686,392
Common stock, 0.001 par value authorized 290,000 shares 143,796 shares issued and 141,135 outstanding as of june 30, 2026 and 138,363 shares issued and 135,702 outstanding as of september 30, 2025
237
236
233
231
Additional paid-in capital
2,443,074
2,395,267
2,211,026
2,139,725
Accumulated other comprehensive (loss) income
-1,234
742
6,699
6,443
Accumulated deficit
-1,923,355
-1,729,075
-1,596,343
-1,627,154
Treasury stock at cost 2,661 shares of common stock at june 30, 2026 and september 30, 2025
53,193
53,193
53,193
53,193
Stockholders equity
465,529
613,977
568,422
466,052
Noncontrolling interest
512
-15,061
-5,725
37,364
Total noncontrolling interest and stockholders equity
466,041
598,916
562,697
503,416
Total liabilities, noncontrolling interest and stockholders equity
2,112,013
2,268,265
1,604,181
1,385,295
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Available-for-sale securities, atfair value$1,547,201K (100.78%↑ Y/Y)Other current assets$35,522K (169.92%↑ Y/Y)Cash, cashequivalents and restricted...$35,074K Prepaid expenses$25,373K (7.10%↑ Y/Y)Cash, cashequivalents and restricted...$19,685K Accounts receivable$8,556K (-11.78%↓ Y/Y)Gross carrying amount$24,857K (0.00%↑ Y/Y)Total current assets$1,671,411K (76.51%↑ Y/Y)Property, plant andequipment, net$373,301K (-2.03%↓ Y/Y)Right-of-use assets$55,667K (26.51%↑ Y/Y)Other assets$6,048K (347.01%↑ Y/Y)Intangible assets, net$5,586K (-23.33%↓ Y/Y)Accumulated amortization$19,271K (9.68%↑ Y/Y)Total assets$2,112,013K (52.98%↑ Y/Y)Total liabilities,noncontrolling interest and...$2,112,013K (52.98%↑ Y/Y)Total long-termliabilities$1,362,626K (104.51%↑ Y/Y)Total noncontrollinginterest and...$466,041K (-10.34%↓ Y/Y)Total currentliabilities$283,346K (45.66%↑ Y/Y)Convertible notes, net$682,707K Liability related to thesale of future...$392,512K (8.95%↑ Y/Y)Credit facility, net ofcurrent portion$141,366K (-29.43%↓ Y/Y)Lease liabilities,net of current...$114,298K (8.14%↑ Y/Y)Deferred revenue, net ofcurrent portion$31,743K Stockholders equity$465,529K (-10.87%↓ Y/Y)Noncontrolling interest$512K (120.42%↑ Y/Y)Deferred revenue$94,596K (311.66%↑ Y/Y)Accrued expenses$86,174K (32.95%↑ Y/Y)Credit facility$40,000K (0.00%↑ Y/Y)Accounts payable$27,776K (-15.96%↓ Y/Y)Accrued payroll andbenefits$23,455K (21.54%↑ Y/Y)Other liabilities$6,023K (-18.33%↓ Y/Y)Lease liabilities$5,322K (-24.08%↓ Y/Y)Accumulated deficit-$1,923,355K (-19.95%↓ Y/Y)Treasury stock at cost2,661 shares of common...$53,193K Accumulated othercomprehensive (loss) income-$1,234K (-123.04%↓ Y/Y)Additional paid-in capital$2,443,074K (15.23%↑ Y/Y)Common stock, 0.001 parvalue authorized...$237K (3.04%↑ Y/Y)

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)